I’d be very surprised if the patent holder sold a full cycle for $6k or less. Antibodies (think cancer drugs) aren’t on the order of magnitude as expensive to produce as they’re sold for, either. Patients will pay whatever they can if the non-human primate results transfer to humans.
I’d be very surprised if the patent holder sold a full cycle for $6k or less. Antibodies (think cancer drugs) aren’t on the order of magnitude as expensive to produce as they’re sold for, either. Patients will pay whatever they can if the non-human primate results transfer to humans.